VA Veterans More Likely to Get Germline Testing With In-Person Consults Premium In particular, Black veterans seen through an on-site program at a Philadelphia VA medical center were nearly five times more likely to get tested than through a telemedicine consult. Personalis Q3 Revenues Down 33 Percent on Disputed VA Contract The revenue drop reflects a hold on the company's ongoing contract to provide sequencing services for the US Department of Veterans Affairs. Natera Awarded Contract to Provide Cancer Testing Services to VA Natera will provide the VA with its Signatera circulating tumor DNA test for minimal residual disease assessment and treatment monitoring. Biodesix Nabs US Federal Supply Schedule Contract for Lung Cancer Tests The company's full lung cancer diagnostic menu will be covered for eligible veterans, active-duty military, and their families. Oncocyte Nets $3M VA Contract for DetermaRx Lung Cancer Prognostic Test The test will be covered by the VA for five years to determine the risk of recurrence in early-stage lung cancer patients after surgery. May 31, 2022 Grail, Veterans Affairs to Evaluate Galleri Cancer Early Detection Test May 6, 2022 Tempus to Provide NGS Cancer Tests to US Department of Veterans Affairs Apr 29, 2022 Castle Biosciences, VHA Expand Supply Contract to Cover Full Skin Cancer Test Portfolio Apr 28, 2022 Million Veteran Program Study Links Genetic Variants Related to Severe COVID-19 to Other Conditions Apr 18, 2022 Clinical Polygenic Risk Assay, Reporting Pipeline Shows Promise for Multiple Conditions Premium Feb 22, 2022 Million Veterans Study Yields Prostate Cancer Risk Score With Promise for Improved Screening Premium Jan 7, 2022 Personalis Reports Preliminary Q4 Revenues up More Than 2 Percent Aug 24, 2021 Castle Biosciences Awarded VA Supply Contract for Melanoma Test Aug 4, 2021 Personalis Q2 Revenues Rise 11 Percent May 5, 2021 Personalis Q1 Revenues Grow 9 Percent Apr 22, 2021 Renalytix AI Lands US Government Contract for Kidney Disease Test Jan 28, 2021 Million Veteran Program GWAS Uncovers Genetic Loci Linked to PTSD Jan 26, 2021 Genomind Receives Medicare Coverage for Pharmacogenetics Test Nov 5, 2020 Personalis Q3 Revenues Up 16 Percent Aug 21, 2020 Single-Cell Analysis Reveals Ulcerative Colitis Tissue, Immune Features Aug 6, 2020 Personalis Q2 Revenues Up 23 Percent May 7, 2020 Personalis Q1 Revenues Up 36 Percent May 7, 2020 Prospective Study Adds Evidence for CellMax Life Liquid Biopsy Utility in CRC Screening Premium Jan 7, 2020 Anxiety GWAS On Million Veteran Program Data Uncovers New Loci Nov 13, 2019 Personalis Q3 Revenues Up 47 Percent Load More Breaking News SARS-CoV-2 Mutational Signature Associated With Mutagenic Antiviral Drug Biocartis Restructures Balance Sheet as H1 2023 Revenues Rise 12 Percent Rare Kidney Cancer Genomic Analysis Reveals Potential Target, Suggests Treatment SEC Concludes CareDx Investigation, Recommends No Enforcement Action Streck Quality Controls for DiaSorin's Luminex Sepsis Tests Receive FDA Clearance The Scan Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants. Small Study of Gene Editing to Treat Sickle Cell Disease In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms. Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema. Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.